Hanmi Pharmaceutical said Wednesday that the company has relaunched its liver function-enhancing OTC drug, "Silyman Soft Capsule 140" (Silyman), after sharply increasing its internal resorption rate.Silyman is a product that dramatically increases the absorption rate of conventional silymarin prepar
A health expert stressed the importance of introducing more accurate diagnostic tests to identify KRAS G12C mutated non-small cell lung cancer (NSCLC) patients that can receive treatment with Amgen's Lumakras.Lumakras is the first KRAS targeted therapy developed 40 years after researchers discovered
ST Pharm said it was having a pre-IND (investigational new drug) meeting with the U.S. FDA for a phase 2 trial of an HIV drug, after completing the phase 1 study in France.The Kosdaq-listed company aims to develop the world’s first cure for HIV.On Monday, ST Pharm said in a public filing that it rec
Korea Pharma said it has signed an exclusive development and commercialization contract for Methydur, a pediatric attention deficit hyperactivity disorder treatment developed by Taiwan's Orient Pharmaceuticals.According to Korea Pharma, Methydur is a pediatric ADHD treatment that received approval i
Eutilex said it has submitted an orphan drug designation (ODD) application for EU204, a killer T-cell treatment targeting Epstein-Barr virus (EBV)-positive cancer patients, to the U.S. Food and Drug Administration.EU204 is undergoing phase 1 and 2a clinical trials in Korea for patients with EBV-posi
Whether AstraZeneca’s anti-PD-L1 immunotherapy Imfinzi (ingredient: durvalumab) will become the first immunotherapy option to treat biliary tract cancer is drawing attention.The U.S. FDA has been reviewing Imfinzi’s indication for biliary tract cancer treatment since May. Observers say that the regu
Roche Diagnostics Korea said Monday it launched three PCR diagnostic products -- LightMix Modular Orthopox Virus, LightMix Modular Orthopox Virus, and LightMix Modular Orthopoxy Virus -- to detect the monkeypox virus with its subsidiary, TIB Molbiol.All these test kits are quantitative PCR tests tha
Pharmbio Korea said on Friday that the company has signed an exclusive supply license agreement for TYMLOS (ingredient name abaloparatide), an osteoporosis treatment of U.S. biopharmaceutical company Radius Health.Osteoporosis is a medical condition that occurs when bones become brittle and fragile
Daewon Pharmaceutical's plan for the overseas advance of its non-steroidal anti-inflammatory drug (NSAID), Pelubi, has ground to a halt because of the prolonging Russian war in Ukraine.Daewon had conducted domestic clinical trials for Pelubi for the past two years to advance to Russia. The company r
T&R Biofab, a 3D bioprinting company, said Thursday that it has obtained a Japanese patent for heart disease treatment technology using induced pluripotent stem cells (iPSCs).The technology is used to manufacture a 3D micro cardiac spheroid, a three-dimensional heart structure of uniform 100 microme
Daewoong Pharmaceutical said Thursday that it has signed a contract development and manufacturing organization (CDMO) agreement with Yonsei University Wonju College of Medicine (YUWCM) to develop stem cell-based hearing loss therapies.With this contract, the two institutions will collaborate to esta
Sanofi Aventis Korea’s labor union criticized management for using excessive and unfair discipline against workers for years and pointed to the company’s Ethics & Business Integrity (E&BI) program as the main culprit.Unionized workers claimed that the E&BI department in Korea misinterpreted the glob
Antiviral drug developer ImmuneMed said Wednesday that its candidate substance for Covid-19 treatment, burfiralimab, will soon enter into phase 3 clinical trials after receiving approval from Indonesia’s National Agency of Drug and Food Control (BPOM).The company said the Indonesian approval marked
Huons said it would supply its local anesthetic product to McKesson, a U.S. drug distribution company, through its U.S. subsidiary Huons USA.Under the accord, Huons plans to export a “5mL vial of 1 percent lidocaine hydrochloride injection,” which received U.S. Food and Drug Administration’s Abbrevi
Chinese pharmaceutical companies, including Antengene, Everest Medicines, and BeiGene, established Korean offshoots recently. Unlike other Chinese companies that used to export drug ingredients to Korea, these companies aim to target the Korean market with innovative drugs for serious diseases like
Daewoong Pharmaceutical said it would develop a chronic skin disease treatment jointly with Scai Therapeutics, a drug delivery platform bio-venture, using transdermal absorption technology.The two companies will apply Scai Therapeutics' proprietary technology to develop a transdermal absorbable form
Novartis Korea said Tuesday that it obtained permission from the Ministry of Food and Drug Safety on June 9, to market Scemblix to treat adults with chronic myeloid leukemia who had received two or more tyrosine kinase inhibitors (TKI).Chronic myeloid leukemia is a malignant blood disease caused by
Helixmith has decided to postpone announcing the interim results of the U.S. phase 3 clinical trial for diabetic peripheral neuropathy (DPN) using its new gene therapy, Engensis (VM202), until next month, its top manager said.The company had planned to share the results of the Independent Data Monit
Celltrion said it would change its strategy for developing a Covid-19 treatment to respond to the rapidly changing pandemic situations after the emergence of the Omicron variant.For instance, the company will scrap its plan to develop an inhaled cocktail antibody treatment that adds CT-P63, a candid
Dae Hwa Pharm said it applied to the drug regulator for a change in the post-marketing surveillance (PMS) plan for Liporaxel (ingredient: paclitaxel), chemotherapy to extend the September deadline of the drug re-evaluation.The Ministry of Food and Drug Safety’s central pharmaceutical review committe